HSA / FSA eligible — use your health savings or flexible spending account

All products are for research purposes only — not for human consumption

Clinical tool · Dosing

GLP-1 dose calculator

Convert a semaglutide or tirzepatide dose in milligrams to units on a standard U-100 insulin syringe, and review the reference weekly titration schedules.

Your vial and dose

Units = (dose in mg ÷ concentration in mg/mL) × 100

Draw on a U-100 syringe

10units

= 0.1 mL of semaglutide at 2.5 mg/mL

050100 units

Important

Units measure volume on a syringe, not a standardized drug amount — the same number of units is a different dose at a different concentration. Always confirm the labeled concentration on your vial and your syringe type before drawing. This tool does not replace guidance from a licensed provider and is not a prescription. Research compounds sold by Lumivive Wellness are for laboratory research use only.

Reference titration

Semaglutide weekly schedule

Half-life ≈ 7 days

Weeks 1–4
0.25 mg weekly
Weeks 5–8
0.5 mg weekly
Weeks 9–12
1.0 mg weekly
Weeks 13–16
1.7 mg weekly
Weeks 17+
2.4 mg weekly (maintenance)

Reference titration

Tirzepatide weekly schedule

Half-life ≈ 5 days

Weeks 1–4
2.5 mg weekly
Weeks 5–8
5 mg weekly
Weeks 9–12
7.5 mg weekly
Weeks 13–16
10 mg weekly
Weeks 17–20
12.5 mg weekly
Weeks 21+
15 mg weekly (maximum)

Schedules above reflect the escalation patterns commonly cited in published GLP-1 literature. Many people hold a lower dose longer when appetite control is already effective or while side effects settle. Any change to a dosing plan should be made with a licensed provider.